AdvanDx Welcome Graphic
AdvanDx Publications 4.23.2008 | Fluorescence in situ hybridization using peptide nucleic acid probes (PNA-FISH) differentiates Staphylococcus aureus from other...
4.21.2008 | The PNA FISH accurately identifies C. albicans and C. glabrata directly from positive blood cultures within hours and can impact on the...
4.21.2008 | The EVIGENE concept showed 97.9% agreement with conventional methods, including 100% sensitivity and 100% specificity on nasal swab.
Learn More About AdvanDx AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available within hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.
More About Us web_award.jpg
AdvanDx News 4.19.2008 | Please visit Booth #501 to learn more about AdvanDx and our products. Also, if you would to schedule an onsite meeting, send an e-mail...

3.19.2008 | Woburn, MA, U.S.A - AdvanDx announced it received Frost & Sullivan's 2008 Technology Innovation of the Year Award in the field of...

3.12.2008 | FOR IMMEDIATE RELEASE